154 related articles for article (PubMed ID: 33364197)
61. Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
Kim KI; Lee KH; Kim TR; Chun YS; Lee TH; Park HK
J Breast Cancer; 2014 Mar; 17(1):40-6. PubMed ID: 24744796
[TBL] [Abstract][Full Text] [Related]
62. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
63.
Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
[TBL] [Abstract][Full Text] [Related]
64. Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer.
Todorova VK; Byrum SD; Gies AJ; Haynie C; Smith H; Reyna NS; Makhoul I
Curr Oncol; 2022 Jan; 29(2):613-630. PubMed ID: 35200555
[TBL] [Abstract][Full Text] [Related]
65. Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Cirmena G; Ferrando L; Ravera F; Garuti A; Dameri M; Gallo M; Barbero V; Ferrando F; Del Mastro L; Garlaschi A; Friedman D; Fregatti P; Ballestrero A; Zoppoli G
JCO Precis Oncol; 2022 Feb; 6():e2100198. PubMed ID: 35201850
[TBL] [Abstract][Full Text] [Related]
66. Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?
Morgan C; Stringfellow TD; Rolph R; Kovacs T; Kothari A; Pinder SE; Hamed H; Sever AR
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):522-526. PubMed ID: 31740186
[TBL] [Abstract][Full Text] [Related]
67. qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer.
Zuo K; Yuan X; Liang X; Sun X; Liu S; Connell PP; Li X; Yang W
Breast Cancer Res Treat; 2022 Jan; 191(2):335-344. PubMed ID: 34797456
[TBL] [Abstract][Full Text] [Related]
68. Prognostic significance of Ki67 during neoadjuvant chemotherapy in primary unresectable ovarian cancer.
Kaya R; Takanashi H; Nakajima A; Saito R; Yamaguchi N; Morimoto K; Isonishi S
J Obstet Gynaecol Res; 2021 Nov; 47(11):3979-3989. PubMed ID: 34396646
[TBL] [Abstract][Full Text] [Related]
69. Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses.
Myller S; Ipatti P; Jääskeläinen A; Haapasaari KM; Jukkola A; Karihtala P
Acta Oncol; 2020 Sep; 59(9):1036-1042. PubMed ID: 32394761
[No Abstract] [Full Text] [Related]
70. Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.
Hayashi M; Yamamoto Y; Ibusuki M; Fujiwara S; Yamamoto S; Tomita S; Nakano M; Murakami K; Iyama K; Iwase H
Ann Surg Oncol; 2012 Sep; 19(9):3042-9. PubMed ID: 22476757
[TBL] [Abstract][Full Text] [Related]
71. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Xu Q; Xu Y; Sun H; Chan Q; Shi K; Song A; Wang W
J Magn Reson Imaging; 2018 Jul; 48(1):248-258. PubMed ID: 29281151
[TBL] [Abstract][Full Text] [Related]
72. Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis.
Zhao Y; Wang X; Huang Y; Zhou X; Zhang D
Clin Transl Oncol; 2020 Jan; 22(1):91-102. PubMed ID: 31006089
[TBL] [Abstract][Full Text] [Related]
73. Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography.
Güç ZG; Turgut B; Avci A; Cengiz F; Eren Kalender M; Alacacioğlu A
Nucl Med Commun; 2022 May; 43(5):560-567. PubMed ID: 35045553
[TBL] [Abstract][Full Text] [Related]
74. Changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer are associated with survival.
Pölcher M; Friedrichs N; Rudlowski C; Fimmers R; Keyver-Paik MD; Kübler K; Sauerwald A; Büttner R; Kuhn W; Braun M
Int J Gynecol Cancer; 2010 May; 20(4):555-60. PubMed ID: 20442588
[TBL] [Abstract][Full Text] [Related]
75. Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins.
Aggarwal V; Agarwal G; Lal P; Krishnani N; Mishra A; Verma AK; Mishra SK
World J Surg; 2008 Dec; 32(12):2562-9. PubMed ID: 18030518
[TBL] [Abstract][Full Text] [Related]
76. Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.
Tasoulis MK; Lee HB; Yang W; Pope R; Krishnamurthy S; Kim SY; Cho N; Teoh V; Rauch GM; Smith BD; Valero V; Mohammed K; Han W; MacNeill F; Kuerer HM
JAMA Surg; 2020 Dec; 155(12):e204103. PubMed ID: 33026457
[TBL] [Abstract][Full Text] [Related]
77. MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy.
Calhoun BC; Portier B; Wang Z; Minca EC; Budd GT; Lanigan C; Tubbs RR; Morrison LE
BMC Cancer; 2016 Aug; 16(1):695. PubMed ID: 27576528
[TBL] [Abstract][Full Text] [Related]
78. Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden.
Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
Breast; 2020 Oct; 53():33-41. PubMed ID: 32563178
[TBL] [Abstract][Full Text] [Related]
79. Neoadjuvant induction chemotherapy.
Schwartz G
Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
[TBL] [Abstract][Full Text] [Related]
80. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]